NCT00018291View on ClinicalTrials.gov

Specific Interventions for Agitation in Alzheimer's Disease

NACompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Study Completion Date

January 31, 2005

Conditions
Alzheimer's DiseaseDementia
Interventions
DRUG

Risperidone

DRUG

Gabapentin

Trial Locations (1)

94025

Palo Alto VA Health Care System, Menlo Park

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00018291 - Specific Interventions for Agitation in Alzheimer's Disease | Biotech Hunter | Biotech Hunter